Juvenescence got $100 million Series B round of financing last week. In fact, their CEO, Greg Bailey, expressed that we will age better than our parents.
“I think the world is going to be shocked,” he said in an interview. Indeed, Juvenescence has now attracted $165 million in just 18 months to fund longevity research in order to extend human lifespans to 150 years.
Investment in Anti-Aging
In addition, Bailey said this capital gives the company the ability to progress all of their products. They have 12 programs based on hard, rigorous science, to try to modify aging. From stem cell research to senolytics to modifying or preventing Alzheimer’s and Parkinson’s diseases.
In addition, Bank of America has forecast the market can reach $610 billion by 2025, from a current $110 billion. “I think there’s a huge amount of skepticism. There’s an enormous number of charlatans…I understand why they would be thinking you know, is this real?” Bailey said in an interview.
“Walk into your local drugstore, you’re going to see about 50 products that claim to be anti-aging, and I can assure you that none of them are.”
Furthermore, Juvenescence has market competition. For example, Life Biosciences is a Boston-based company founded in 2016 by scientists David Sinclair and Tristan Edwards to develop eight pathways of age-related decline.
“In January, Life Biosciences raised $50 million in a Series B financing – twice its original target – to grow its portfolio of ‘daughter companies’ which carry out their own research and development programs,” Market Watch reported.
In addition, Rejuvenate Bio is another start-up, co-founded by Harvard Medical School professor George Church. What is more, this company is researching 60 different age-reversing gene therapies.
“The company, which carried out initial tests on beagles, claims it can reverse aging in animals by adding new DNA instructions to their bodies. It has announced plans to launch a trial later this year to combat mitral valve disease, a condition which is common in the Cavalier King Charles Spaniel breed and directly caused by ageing.”
Besides, healthier, longer lifespans with new tissues and organs can become a reality sooner than most people can imagine. “We are just learning so much so fast,” Greg Bailey said.
The future now
“It’s happening now. It’s not in the future, and it will happen faster than people think. The potential to regrow a lung or a limb is extraordinary.”
Besides, the study of aging and longevity is becoming more popular. Venture capitalist Sergey Young, who is in charge of all things longevity at the non-profit XPRIZE and VC fund BOLD Capital Partner, revealed a $100 million fund.
“Google-owned stealthy biotech Calico is after the same prize — and has partnered with AbbVie $ABBV.”
Finally, Greg Bailey expressed an analogy for people to consider the pace of the development of this field.
“In 1903, two brothers flew a glorified kite for 14 seconds, the Kitty Hawk. Fifteen years later they were flying planes in WWI, and 35 years later, the Germans had invented the jet. Sixty-five years later we landed a man on the moon. For robotics and for aging, divide that number by 10. That’s how fast this is going to happen.”